Replimune reduces ATM offering capacity from $100M to $89M, suspends sales

Replimune Group, Inc.

Aggregate offering amount cut from $100M to $89M via Amendment No. 2 dated Nov 25, 2024.
Company suspending ATM prospectus; no sales until new prospectus or registration statement filed.
Amendment entered with Leerink Partners LLC; Sales Agreement otherwise remains in effect.
Reduction and suspension are precautionary; no current sales are being made under ATM.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.